These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12577994)

  • 1. Imaging-guided extension of the time window: ready for application in experienced stroke centers?
    Röther J
    Stroke; 2003 Feb; 34(2):575-83. PubMed ID: 12577994
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical acute stroke evaluation.
    Lutsep HL
    Neuroimaging Clin N Am; 1999 Aug; 9(3):401-9. PubMed ID: 10433634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case of the day.
    Gupta R
    J Emerg Med; 2002 Nov; 23(4):421-2. PubMed ID: 12480030
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute thrombolytic therapy in stroke: focus on the 3- to 6-hour time window.
    Gorman MJ
    Ethn Dis; 2002; 12(1):S1-54-7. PubMed ID: 11913622
    [No Abstract]   [Full Text] [Related]  

  • 5. Imaging helps identify who benefits from stroke intervention.
    Yuh WT; Taoka T; Ueda T; Chaloupka JC
    Diagn Imaging (San Franc); 1999 Dec; 21(12):77-82. PubMed ID: 10724845
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status.
    Schellinger PD; Fiebach JB; Hacke W
    Stroke; 2003 Feb; 34(2):575-83. PubMed ID: 12574579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Programs for continuing medical education: a session; 4. Diagnosis and treatment for acute stroke].
    Kimura K
    Nihon Naika Gakkai Zasshi; 2013 Mar; 102(3):612-7. PubMed ID: 23777146
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggregation of marginal gains in the care of acute stroke.
    O'Brien A; Guyler P
    Br J Hosp Med (Lond); 2009 Mar; 70(3):154-6. PubMed ID: 19274005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays.
    Monks T; Pitt M; Stein K; James M
    Stroke; 2012 Oct; 43(10):2706-11. PubMed ID: 22895996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three hours.
    Smith SD
    Minn Med; 2005 Aug; 88(8):20-3. PubMed ID: 16225330
    [No Abstract]   [Full Text] [Related]  

  • 12. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 13. MRI and stroke: why has it taken so long?
    Donnan GA; Dewey HM; Davis SM
    Lancet; 2007 Jan; 369(9558):252-4. PubMed ID: 17258648
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IV and IA thrombolytic stroke strategies are complementary.
    Donnan GA; Davis SM
    Stroke; 2009 Jul; 40(7):2615. PubMed ID: 19443794
    [No Abstract]   [Full Text] [Related]  

  • 16. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
    Schellinger PD; Köhrmann M
    Stroke; 2014 Mar; 45(3):912-3. PubMed ID: 24526060
    [No Abstract]   [Full Text] [Related]  

  • 17. Academic-Community Hospital Comparison of Vulnerabilities in Door-to-Needle Process for Acute Ischemic Stroke.
    Prabhakaran S; Khorzad R; Brown A; Nannicelli AP; Khare R; Holl JL
    Circ Cardiovasc Qual Outcomes; 2015 Oct; 8(6 Suppl 3):S148-54. PubMed ID: 26515203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
    Wechsler LR
    Stroke; 2014 Mar; 45(3):914-5. PubMed ID: 24526061
    [No Abstract]   [Full Text] [Related]  

  • 19. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
    Fink J
    N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current acute stroke trials and their potential impact on the therapeutic time window.
    Schellinger PD; Köhrmann M
    Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.